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To study the mechanism of curcumin-attenuated inﬂammation and liver pathology in early stage of alcoholic liver disease, female
Sprague-Dawley rats were divided into four groups and treated with ethanol or curcumin via an intragastric tube for 4 weeks. A
control group treated with distilled water, and an ethanol group was treated with ethanol (7.5g/kgbw). Treatment groups were fed
with ethanol supplemented with curcumin (400 or 1200mg/kgbw). The liver histopathology in ethanol group revealed mild-to-
moderatesteatosisandmildnecroinﬂammation.HepaticMDA,hepatocyteapoptosis,andNF-κBactivationincreasedsigniﬁcantly
in ethanol-treated group when compared with control. Curcumin treatments resulted in improving of liver pathology, decreasing
the elevation of hepatic MDA, and inhibition of NF-κB activation. The 400mg/kg bw of curcumin treatment revealed only a trend
of decreased hepatocyte apoptosis. However, the results of SOD activity, PPARγ protein expression showed no diﬀerence among
the groups. In conclusion, curcumin improved liver histopathology in early stage of ethanol-induced liver injury by reduction of
oxidative stress and inhibition of NF-κB activation.
Copyright © 2009 Suchittra Samuhasaneeto et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
Alcoholic liver disease (ALD) represents a spectrum of
clinical illness and morphological changes that range from
fatty liver, hepatic inﬂammation, and necrosis (alcoholic
hepatitis) to progressive ﬁbrosis (alcoholic cirrhosis) [1].
Many of the toxic eﬀects of ethanol in the liver have been
associated with its metabolism. Ethanol oxidation generates
toxic products such as acetaldehyde, and reactive oxygen
species result in oxidative stress that initiates apoptosis and
cell injury [2–5].
NF-κB is a transcription factor which regulates genes
involving in inﬂammation. It is activated by endotoxin,
cytokines, and oxidative stress [6]. In unstimulated cells, NF-
κB is a heterodimeric complex that is sequestered in the
cytoplasm by its interaction with IκB family of inhibitors.
When these cells are stimulated, IκB is phosphorylated with
subsequent release of NF-κB resulting in the translocation of
NF-κB from the cytoplasm to the nucleus where it activates
the expression of target genes [7, 8]. Activation of NF-
κB increased expression of proinﬂammatory cytokines and
chemokines that were key factors in ethanol-induced liver
injury rats [9–12].
Peroxisome proliferators activated receptors gamma
(PPARγ) is a family of ligand-activated nuclear transcrip-
tional factor which regulates cell diﬀerentiation, apoptosis,
lipid metabolism, and inﬂammation [13]. More recently,
decreased expression of PPARγ has been found in rats with
alcoholic liver ﬁbrosis. These suggested that PPARγ may
play an important role in the development of hepatocellular
inﬂammation, necrosis, and ﬁbrosis in rats with ethanol
consumption [14].2 Journal of Biomedicine and Biotechnology
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Figure1:Hematoxylin-eosin-stainedliversections(x400).(a)Controlgroupshowednormalliverhistopathology.(b)Ethanol-treatedgroup
showedsteatosis(smallarrows)andinﬁltrationofinﬂammatorycells(blockarrow).(c)and(d)Curcumintreatment(400or1,200mg/kgbw
a day) showed examples of improvement in steatosis and inﬂammation.
Curcumin (diferuloylmethane), an antiinﬂammatory
and antioxidant compound, is isolated from the rhizomes
of the plant Curcuma longa Linn. Importantly, it has been
showed that curcumin suppressed the activation of NF-
κB in ethanol-induced liver injury in rats [10]. Activation
of PPARγ by curcumin resulted in inhibition of NF-κB
transactivating activity and increased expression of PPARγ at
both the transcriptional and translational levels in activated
hepatic stellate cells (HSCs) [15].
However, it is unclear whether curcumin had any eﬀect
in early stage of ethanol-induced liver injury. Therefore, the
present study determined the eﬀect of curcumin on early
stage of ethanol-induced liver inﬂammation and improved
pathology in rats.
2.MaterialsandMethods
2.1. Animal Preparation. Female Sprague-Dawley rats,
weighing 180–220 grams, purchased from the National
Laboratory Animal Center, Mahidol University, Salaya,
Nakorn pathom, were used. The rats were kept in a
c o n t r o l l e dt e m p e r a t u r er o o ma t2 5± 1◦C under standard
conditions (12-hour day-night rhythm). All rats were
received well care in accordance with the Ethical Committee,
Faculty of Medicine, Chulalongkorn University, Thailand.
2.2. CurcuminPreparation. Curcumin in powder form (Cay-
man Chemical Company, USA) is dissolved in 50% ethanol
that freshly prepared for the experiment.
2.3. Experimental Protocol. All rats were fed with the con-
trolled diet which contained 35% of energy from fat, 18%
from protein, and 47% from carbohydrate for 4 weeks
ad libitum [16]. They were randomly divided into four
experimental groups.
Group 1 (Control, n = 8): rats were fed distilled water
(2.0mL) orally via an intragastric tube once per day for 4
weeks.
Group 2 (Ethanol, n = 8): rats were fed 50% ethanol
(7.5g/kgbw a day) orally via an intragastric tube twice a day
for 4 weeks.
Group 3 (Ethanol + curI, n = 6): rats were fed curcumin
(200mg/kgbw) dissolved in 50% ethanol (7.5g/kgbw a day)
via intragastric tube twice a day for 4 weeks.
Group 4 (Ethanol + curII,n = 7 ) :ra t sw e r ef edc u r c u m i n
(600mg/kgbw)dissolvedin50%ethanol(7.5g/kgBWaday)
by using intragastric tube twice a day for 4 weeks.
At the end of the study, all rats were sacriﬁced
using intraperitoneal injection of an overdose of thiopental
sodium. The abdominal walls were opened, and the whole
liverwasremoved. Threesmallpiecesofliverswerecollected,
frozen in liquid nitrogen, and stored at −80
◦Cf o rM D A
analysis, SOD activity, and PPARγ protein expression. The
remaining of liver was ﬁxed in 10% formalin solution to
determine histopathology, NF-κB activation, and hepatic
apoptosis.
2.4. Histopathological Examination. After the liver samples
were ﬁxed in 10% formalin solution at room temperature,Journal of Biomedicine and Biotechnology 3
they were processed by the standard method. Brieﬂy, tissues
were embedded in paraﬃn, sectioned at 5μm, and stained
with Hematoxylin-Eosin, and then picked up on glass slides
for light microscopy. All samples were evaluated by an
experienced pathologist who is blinded to the experiment.
All ﬁelds in each section were examined for grading of
steatosis and necroinﬂammation according to Colantoni
et al.’s criteria [17].
Steatosis was scored as the percentage of parenchymal
cells containing fat (micro- or macrosteatosis):
0 = no parenchymal cells containing fat,
1 = <20% of parenchymal cells containing fat,
2 = 20–39% of parenchymal cells containing fat,
3 = 40–50% of parenchymal cells containing fat,
4 = >51% of parenchymal cells containing fat.
Inﬂammation and necrosis were scored by the number
of foci of inﬂammation and necrosis identiﬁed under low-
p o w e rﬁ e l do fl i g h tm i c r o s c o p e :
0 = no inﬂammation and necrosis,
1 = 1 focus per low-power ﬁeld of inﬂammation and
necrosis,
2 = 2f o c ip e rl o w - p o w e rﬁ e l do fi n ﬂ a m m a t i o na n d
necrosis,
3 = 3 or more foci per low-power ﬁeld of inﬂamma-
tion and necrosis.
2.5. Hepatic Malondialdehyde (MDA) Determination. MDA
wasassayedbydeterminingtherateofproductionofthiobar-
bituric acid-reactive components [18]. One gram of the liver
was homogenized in 1.15% KCl buﬀer on ice. An aliquot of
0.2mL was mixed with solution containing 20% acetic acid,
0.8% thiobarbituric acid, and 8.1% sodium dodecyl sulfate,
heatedinwaterbathat95
◦Cfor60minutes.Thesolutionwas
centrifuged for 10 minutes at 4000rpm, and the absorbance
of the supernatant fraction was determined at a wavelength
of 546nm. The content of MDA was expressed in terms of
nmol/mg protein.
2.6. Hepatic Superoxide Dismutase (SOD) Activity. SOD was
determined using the method of Winterbourn, in which the
light-triggered release of superoxide radicals from riboﬂavin
leads to the formation of a blue complex through reaction
with nitroblue tetrazolium [19]. One gram of the liver
was homogenized in 0.1M phosphate buﬀer pH 7.4 on ice
and cleared by centrifugation at 3000rpm at 4◦Cf o r1 5
minutes. The supernatant fraction was incubated in solution
containing 0.067M phosphate buﬀer pH 7.8, 0.1M EDTA,
1.5mM NBT and 0.12mM riboﬂavin for 10 minutes in
an illuminated chamber with an 18W ﬂuorescent lamp.
Absorbance was recorded at 560nm, and SOD activity was
expressed as units/mg protein.
2.7. Hepatic Apoptosis Determination. Apoptosis was mea-
sured by the identiﬁcation of apoptotic nuclei in sections of
liver by fragment end labeling of DNA (Apoptosis detection
kit, Chemicon, USA). In brief, endogenous peroxidase
activity was inactivated by 3% hydrogen peroxide (H2O2).
The DNA fragmentswere allowedtobind anantidigoxigenin
antibody that was conjugated to a peroxidase. Diaminoben-
zidine (DAB) was applied to develop dark brown color and
then the slides were counterstained with hematoxylin. All
ﬁelds in each sample were evaluated for positive stained liver
cell. The results were expressed as the number of positive
stained cells per high-power ﬁeld.
2.8. Immunohistochemistry for Expression of NF-κBp 6 5i n
Liver. The liver sections were deparaﬃnized with xylene
and ethanol for ten minutes. After water washing, sections
retrieved the antigen (NF-κB p65, Santa Cruz, USA) with
citrate buﬀer pH 6.0 in microwave for thirteen minutes.
Next, 3% H2O2 and3%normalhorseserumwereperformed
on the slides to block endogenous peroxidase activity for
ﬁve minutes and blocked nonspeciﬁc binding for twenty
minutes, respectively. Then, the primary antibody used for
NF-κB p65, a polyclonal antibody against the p65 subunit,
was applied at a dilution of 1:150 for one hour at room
temperature and incubated with the secondary antibody
for thirty minutes. When the development of the color
with DAB was detected, the slides were counterstained with
hematoxylin.
Under light microscopy, the positive stained cells pre-
sented dark brown in nucleus. The results were expressed as
the number of positive stained cells per high-power ﬁeld.
2.9. Western Blot Analysis of PPARγ Protein Expression in
Liver. Liver sample (0.1g) was homogenized in 1mL of lysis
buﬀer for 30 minutes on ice and cleared by centrifugation
at 12000rpm for 15 minutes at 4◦C. Protein concentration
was assessed by the Lowry method [20]. A 60μgo fp r o t e i n
was applied to 10% SDS-PAGE gel, and the fractionated
proteins were transferred to polyvinylidene ﬂuoride mem-
brane. Membrane was blocked in TBST containing 5%
dry nonfat milk for 1 hour and then incubated with
PPARγ monoclonal antibodies (1:400, Santa Cruz, USA)
overnight at 4◦C. Then washed three times and incubated
with secondary antibody, goat antimouse IgG horseradish
peroxidase (1:4,000, Cayman, USA) for 1 hour. Protein band
was visualized by ECL western blotting system (Amersham,
USA). The band densities were normalized by β-actin using
aS c i o nI m a g es y s t e m .
2.10. Data Analysis. All data were presented as means and
standard deviation (SD). For comparison among all groups
of animals, one way analysis of variance (one-way ANOVA)
and Tukey posthoc comparisons were employed. Diﬀerences
were considered statistically signiﬁcant at P<. 05.
3. Results
3.1. Histopathological Examination. The histologic appear-
ance of the liver in the control group was normal
(Figure 1(a)). In the ethanol-treated group, the histologic4 Journal of Biomedicine and Biotechnology
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Figure 2: Hepatic MDA levels in all groups. All data are expressed
as mean ± SD. The hepatic MDA levels were signiﬁcantly higher in
the ethanol-treated group (Ethanol) when compared with control
group(aP<. 05). Two doses of curcumin treatment (Ethanol + curI
and Ethanol + curII) decreased signiﬁcantly hepatic MDA levels
when compared with Ethanol (bP<. 05).
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Figure 3: Hepatic SOD activity in all groups. All data are expressed
as mean ± SD. No signiﬁcant diﬀerences were observed among
groups.
features showed mild to moderate steatosis and mild
necroinﬂammation (Figure 1(b)). Rats treated with ethanol
and curcumin 400mg/kgbw a day improved the liver
histopathology that showed only mild steatosis but not
necroinﬂammation(Figure 1(c)).Thehighdoseofcurcumin
treatment (1,200mg/kgbw a day) also improved the liver
histopathology that showed mild steatosis and mild necroin-
ﬂammation (Figure 1(d)). The summary of steatosis and
necroinﬂammation score were shown in Table 1.
3.2. Hepatic MDA Level. T h el e v e lo fh e p a t i cM D A ,am a r k e r
of lipid peroxidation, increased signiﬁcantly in ethanol-
treated group as compared with control group (3.42 ± 1.36
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Figure 4: Number of apoptosis cells in all groups. All data are
expressedasmean ±SD.Ethanol-treatedgroup(Ethanol)increased
signiﬁcantly apoptotic cells when compared with control group
(aP<. 05).
Table 1: Summary of steatosis and necroinﬂammation score in all
groups. Data are expressed as the number of rats exhibiting the
grade of steatosis or necroinﬂammation indicated.
Group Number
Steatosis
a Necroinﬂammation
b
012340123
Control 8 8 ———— 8 — — —
Ethanol 8 — 161 — —8— —
Ethanol + curI 6 5 1— — —6 ———
Ethanol + curII 74 3 — — — 3 4 — —
aThe severity of steatosis was grade by the following. 0 = no parenchymal
cells containing fat, 1 = <20% of parenchymal cells containing fat, 2 = 20–
39% of parenchymal cells containing fat, 3 = 40–50% of parenchymal cells
containing fat, 4 = >51% of parenchymal cells containing fat.
bThe severity of necroinﬂammation was grade by the following. 0 = no
inﬂammationandnecrosisunderlow-powerﬁeld,1=1focusperlow-power
ﬁeld, 2 = 2f o c ip e rl o w - p o w e rﬁ e l d ,3= 3o rm o r ef o c ip e rl o w - p o w e rﬁ e l d .
versus 1.44 ± 0.24nmol/mg protein, P<. 05). Curcumin
treatment (400 or 1,200mg/kgbw a day) decreased the
elevation of hepatic MDA level signiﬁcantly when compared
with ethanol-treated group (1.43 ± 0.14 versus 3.42 ± 1.36
and 1.43 ± 0.29 versus 3.42 ± 1.36nmol/mg protein, resp.;
P<. 05) (Figure 2).
3.3. Hepatic SOD Activity. S O De n z y m ec o n v e r t sO 2
− into a
less toxic product. This enzyme is the ﬁrst line in cell defense
against oxidative stress. Our results showed that the level of
hepatic SOD activity of the control group was 1081.36 ±
145.01units/mg protein, while that of the ethanol-treated
group was 1135.86 ±209.48units/mg protein. In rats treated
with ethanol and curcumin (400 or 1,200mg/kgbw a day),
the levels of hepatic SOD activity were 966.28 ± 139.44 and
967.84 ±116.66units/mg protein, respectively. There was no
signiﬁcant diﬀerence among groups (Figure 3).Journal of Biomedicine and Biotechnology 5
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Figure 5: Representative liver sections processed for apoptosis assay by TUNEL reaction (x400). (a) Control group. (b) Ethanol-treated
group, the black arrows indicated a TUNEL-positive apoptoic hepatocyte found frequently around central vein. (c) and (d) curcumin
treatment (400 or 1,200mg/kgbw a day) showed a decrease of apoptotic hepatocytes.
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Figure 6: Number of NF-κB p65 positive cells/high-power ﬁeld in
all groups. All data are expressed as mean ± SD. Ethanol-treated
group (Ethanol) increased signiﬁcantly NF-κBp 6 5p o s i t i v ec e l l s
when compared with control group (aP<. 05). Two doses of
curcumintreatment(Ethanol+curIandEthanol+curII)decreased
signiﬁcantly NF-κB p65 positive cells when compared with Ethanol
(bP<. 05).
3.4. Hepatic Apoptosis. Hepatocyte apoptosis was deter-
mined by TUNEL assay. The number of apoptotic nuclei in
theliverofcontrolgroupwasverylow(0.38±0.28cells/high-
power ﬁeld). In contrast, the numbers of apoptotic cells were
observed frequently in centrilobular area in ethanol-treated
group when compared with control group (2.43 ± 2.68
versus 0.38 ± 0.28cells/high-power ﬁeld, P<. 05) (Figures
4 and 5). There was a trend of decreased apoptosis in low
dose of curcumin treatment, but the diﬀerence did not reach
a statistical signiﬁcance (Figure 4).
3.5. Expression of NF-κBp 6 5i nL i v e r . The expression of NF-
κB p65 in liver was determined by immunohistochemistry.
The data of NF-κBp 6 5e x p r e s s i o ni na l lg r o u p sw e r eg i v e n
in Figure 6. The number of positive stained cells in the
liver of ethanol-treated group was signiﬁcantly higher than
control group (1.08 ± 0.52 versus 0.04 ± 0.04cells/high-
power ﬁeld, P<. 05). In contrast, curcumin treatment (400
or 1,200mg/kgbw a day) decreased the number of positive
stained cells signiﬁcantly when compared with ethanol-
treated group (0.15±0.02 versus 1.08±0.52 and 0.17±0.09
versus 1.08 ± 0.52cells/high-power ﬁeld, resp.; P<. 05)
(Figures 6 and 7).
3.6. PPARγ Protein Expression in Liver. I no r d e rt oe x a m i n e
the change of PPARγ protein expression in early stage of
ethanol-induced liver injury, we measured PPARγ protein
expression in the liver. The PPARγ protein expression in
control group was 0.57 ± 0.19, and ethanol group was
0.68 ± 0.16. Rats treated with ethanol and curcumin (400
or 1,200mg/kgbw a day) had 0.44 ± 0.03 and 0.54 ± 0.23,6 Journal of Biomedicine and Biotechnology
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Figure 7: Immunohistochemistry of NF-κB p65 expression in rat liver (x400). (a) Control group. (b) Ethanol-treated group showed NF-κB
p65 positive cells in nuclei (black arrow). (c) and (d) curcumin treatment (400 or 1,200mg/kgbw a day) showed a diminishment of NF-κB
expression in hepatocyte nuclei.
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Figure 8: PPARγ protein expression determined by Western
blot analysis. (a) represented bands of PPARγ and β-actin. (b)
normalized densitometric ratio of PPARγ to β-actin.
respectively. These data did not show a signiﬁcant change in
PPARγ proteinexpressionintheliverinallgroups(Figure 8).
4. Discussion
Ethanol oxidation generates toxic metabolites, free radicals;
and induces a state of oxidative stress which contributes to
the pathogenesis of ALD. Importantly, oxidation of ethanol
through the cytochrome P450 2E1 (CYP 2E1) generates
superoxide anion radical and hydrogen peroxide [2, 21,
22] .T h e s ef r e er a d i c a l sa r ec a p a b l eo fd a m a g i n gm a n y
cellular components such as DNA, protein, and lipid [23].
One of the characteristic features of oxidative stress is
enhancement of lipid peroxidation. A number of studies
have been demonstrated that ethanol intake increased the
formation of lipid peroxidation product, such as MDA [24–
26]. We found that an increase in hepatic MDA level as well
as pathological changes were observed in ethanol-treated
group.
To counteract this oxidative stress, cells have a vari-
ety of antioxidant enzymes, including SOD, catalase, and
glutathione peroxidase. SOD catalyzes the rapid removal
of superoxide radicals [27]. The eﬀects of chronic ethanol
exposure on activity of SOD are controversial, with
reports of decrease or no changes [25, 28]. These stud-
ies may reﬂect variations in experimental design, diet,
and duration of ethanol feeding. Decreased SOD activity
in ethanol fed rats was associated with enhancement of
lipid peroxidation and severe pathology of liver [25]. Our
model showed mild histopathology changes in both steato-
sis and necroinﬂammation. Therefore, the SOD activity
in liver did not change in early ethanol-induced liver
injury.Journal of Biomedicine and Biotechnology 7
Oxidativestresscanalsoinitiateoramplifyinﬂammation
through upregulation of several genes involved in the
inﬂammatory response. One such gene is NF-κB, whose
activation results in the upregulation of proinﬂammatory
cytokines [6]. Activation of NF-κB and upregulation of
cytokine production occurred in ethanol-induced liver
injury and are associated with lipid peroxidation [9, 10]. Our
study conﬁrmed induction of NF-κB activation in ethanol-
treated group. Curcumin is known as antioxidant and
antiinﬂammatory properties. It is the free radical scavenger
and inhibited lipid peroxidation product [29–32]. Evidence
was presented that curcumin prevented ethanol-induced
liver injury in rats by inhibiting the expression of NF-κB-
dependent genes [10]. Although, a high dose of curcumin
treatment (1,200mg/kgbw) was not better than low dose
(400mg/kgbw), the present study showed that curcumin
improved ethanol-induced liver injury by reduction of
oxidative stress and inhibition of NF-κB activation.
Ethanol-induced liver injury has been linked to oxida-
tive stress caused by the production of reactive oxygen
intermediates that cause mitochondrial dysfunction, leading
to a release of proapoptotic factors such as cytochrome
c that can activate caspases and initiate the apoptotic
cascade in hepatocytes [33]. Jin and coworker observed
the pathological changes and investigated the correlation of
hepatocyte apoptosis with CYP2E1 expression and oxygen
free radical in rats with ALD [34]. Using the TUNEL assay,
wedetectedadiﬀerenceinapoptosisbetweenthecontroland
ethanol-treated group that was similar to human alcoholic
hepatitis and experimental rat model of ALD [33–35]. Cells
in centrilobular area are low O2 and nutrient supply thus
the distribution of apoptotic cells is observed frequently in
centrilobular area [36]. In this study curcumin treatment did
n o td e t e c tad i ﬀerence in hepatocyte apoptosis; however, this
was a trend of decreased apoptosis in low does of curcumin
treatment.
More recently, decreasing of PPARγ expression was
found in alcoholic liver ﬁbrosis rats [14]. This stage showed
severe liver injury and HSC activation. In normal liver, HSCs
undergo a process known as activation, which upregulate
cytokines and growth factor. For instance, platelet-derived
growth factor is capable of inhibiting PPARγ expression via
mitogen-activated protein kinase-mediated phosphorylation
of PPARγ [37]. Also, TNF-α, inﬂammatory cytokine, is
known to inhibit PPARγ expression in adipocytes and an
early phase of HSC activation in liver ﬁbrosis [38, 39], thus
alcoholic liver ﬁbrosis rats could decrease PPARγ expression.
Our model showed only mild steatosis, necroinﬂammation,
and no HSC activation; therefore, no change of PPARγ
protein expression was found in ethanol-treated group.
Further studies should be determined roles of PPARγ in
diﬀerent stages of ALD.
In conclusion, our study demonstrated that curcumin, a
representative phenolic antioxidant and antiinﬂammmation,
could improve histopathology of liver in early stage of
ethanol-induced liver injury by reduction of oxidative stress
and inhibition of NF-κB activation. For hepatocyte apop-
tosis, curcumin treatment might have a trend of decreased
apoptotic cells in ethanol-fed rats.
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